Clinical Trial Update: Efficacy Study of Apremilast (CC-10004) in Subjects With Erosive Hand Osteoarthritis [Phase 2]

View source ↗

Summary

A Phase 2 efficacy study of apremilast (CC-10004) for erosive osteoarthritis of the hand has completed. This update reports the trial status and outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Osteoarthritis of the Hand

Drugs mentioned

• Apremilast (Otezla) (apremilast)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Erosive Osteoarthritis of the Hand | Phase 2 | Status: COMPLETED